In a groundbreaking presentation at the RNA Society’s 30th Annual Meeting, Cofactor Genomics showcased their innovative work merging RNA analysis with artificial intelligence to revolutionize precision medicine in immunotherapy. The latest validation results for OncoPrism®, Cofactor’s cutting-edge RNA diagnostic tool, were unveiled, demonstrating the potential for personalized treatment strategies in cancer therapy. By harnessing the […]
Tag: precision medicine
HLA Gene Editing in RheumaGen for Autoimmune Disorders
A breakthrough clinical trial in gene editing by RheumaGen is revolutionizing the treatment of autoimmune disorders. RG0401 targets specific HLA alleles to encode molecules found in individuals resistant to rheumatoid arthritis. By extracting a patient’s hematopoietic stem cells (HSCs) and introducing engineered HLA alleles ex vivo, the therapy aims to create cells with modified HLA […]
